Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave s Q4 Revenues Drop 28 Percent, Net Losses Widen

NEW YORK, Feb. 28 (GenomeWeb News) - Third Wave today reported a 28-percent drop in fourth-quarter revenues as its quarterly net loss inched upward for the quarter.

 

Third Wave's revenues for the three months ended Dec. 31, 2005, fell to $5.8 million from $8.1 million in the fourth quarter last year.

 

While Third Wave did not provide a reason for the fourth-quarter revenue decline, the company experienced an approximately 50-percent drop in full-year revenues that it blamed on a previously announced and anticipated decline in non-recurring research revenue, which decreased by $23.7 million in 2005, and on $6.9 million in litigation expense incurred defending its core patents last year.

 

Third Wave spent $1.8 million on R&D in Q4 2005 as compared to $2.9 million in same quarter one year prior.

 

The company's quarterly net losses increased to $5 million from $4.7 million in the year-ago period, while the company's net loss for the full year grew to $22.3 million from $1.9 million in 2004.

 

In December, Third Wave paid off a $9.5-million bank note. As of Dec. 31, 2005, the company had cash, cash equivalents, and short-term investments totaling $38.7 million.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.